Trial Details

COMPLETED
Basic Information
Clinical ID c1390
Identifier NCT01456052
Trial Title A Study to Evaluate Safety and Efficacy of Telotristat Etiprate (LX1606) in Participants With Acute, Mild to Moderate Ulcerative Colitis
Trial URL Visit Original Page
Study Information
Study Results

YES
Conditions Ulcerative Colitis
Interventions DRUG: Telotristat Etiprate|DRUG: Placebo
Participant Information
Sponsor Lexicon Pharmaceuticals
City Little Rock
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2012-01-30
Primary Completion Date 2013-09-03
Completion Date 2013-09-03